Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 17.38 is 73% above its 5-year average of 10.03, near the high end of its 5-year range (0.36–20.41).
As of the fiscal period ended Tuesday, June 30, 2026. 14.12% above its 12-month average of 15.23.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.38.
CURRENT RATIO
17.38
CURRENT RATIO AVG TTM
15.23
CURRENT RATIO AVG 3Y
10.41
CURRENT RATIO AVG 5Y
10.03
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+14.12%
CURRENT VS 3Y AVG
+67.02%
CURRENT VS 5Y AVG
+73.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+363.55%
vs the sector median at left
Whitehawk Therapeutics Inc
Market Cap
$204.66M
Current Ratio
17.38
TTM Avg
15.23
3Y Avg
10.41
5Y Avg
10.03
Market Cap
$203.03M
Current Ratio
7.48
TTM Avg
9.04
3Y Avg
6.33
5Y Avg
4.86
Market Cap
$206.79M
Current Ratio
20.05
TTM Avg
17.55
3Y Avg
12.54
5Y Avg
12.54
Market Cap
$208.68M
Current Ratio
10.89
TTM Avg
11.84
3Y Avg
8.89
5Y Avg
15.32
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc (WHWK) | $204.66M | 17.38 | 15.23 | 10.41 | 10.03 |
| Electra Therapeutics Inc. (ETRA)vs › | $205.97M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $203.03M | 7.48 | 9.04 | 6.33 | 4.86 |
| Sionna Therapeutics, Inc. (SION)vs › | $206.79M | 20.05 | 17.55 | 12.54 | 12.54 |
| Exagen Inc. (XGN)vs › | $200.72M | 3.18 | 3.08 | 4.43 | 6.31 |
| Pro-Dex, Inc. (PDEX)vs › | $207.97M | 4.10 | 3.67 | 3.34 | 3.14 |
| Entrada Therapeutics, Inc. (TRDA)vs › | $208.68M | 10.89 | 11.84 | 8.89 | 15.32 |
| Surrozen, Inc. (SRZN)vs › | $198.79M | 12.14 | 7.27 | 7.16 | 7.21 |
| Compugen Ltd. (CGEN)vs › | $210.71M | 5.72 | 5.91 | 5.85 | 7.15 |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $209.80M | 344.31 | 177.51 | 95.19 | 76.57 |
Current Ratio
17.38
Quick Ratio
17.38
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 17.38 |
| 2026-03-31 | 11.36 |
| 2025-12-31 | 10.26 |
| 2025-09-30 | 16.76 |
| 2025-06-30 | 20.41 |
| 2025-03-31 | 18.95 |
| 2024-12-31 | 3.59 |
| 2024-09-30 | 4.89 |
| 2024-06-30 | 4.20 |
| 2024-03-31 | 5.16 |
| 2023-12-31 | 4.72 |
| 2023-09-30 | 6.48 |
| 2023-06-30 | 11.15 |
| 2023-03-31 | 9.29 |
| 2022-12-31 | 9.56 |
| 2022-09-30 | 10.61 |
| 2022-06-30 | 9.87 |
| 2022-03-31 | 11.78 |
| 2021-12-31 | 9.90 |
| 2021-09-30 | 14.01 |
| 2021-06-30 | 0.36 |
| 2021-03-31 | 0.46 |
| 2020-12-31 | 0.62 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
